Christopher Fuglesang's Net Worth
$194 Million
Who is Christopher Fuglesang?
Christopher Fuglesang has an estimated net worth of $194 Million. This is based on reported shares across multiple companies, which include Mirati Therapeutics, Inc., BCTG Acquisition Corp., and Pandion Therapeutics, Inc..
SEC CIK
Christopher Fuglesang's CIK is 0001465835
Past Insider Trading and Trends
2017 was Christopher Fuglesang's most active year for acquiring shares with 6 total transactions. Christopher Fuglesang's most active month to acquire stocks was the month of December. 2021 was Christopher Fuglesang's most active year for disposing of shares, totalling 10 transactions. Christopher Fuglesang's most active month to dispose stocks was the month of September. 2023 saw Christopher Fuglesang paying a total of $69,998,898.80 for 2,517,946 shares, this is the most they've acquired in one year. In 2021 Christopher Fuglesang cashed out on 3,156,577 shares for a total of $207,220,386.15, their largest year based on trade value.
Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!
Mirati Therapeutics, Inc. (MRTX) No price found
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| -100.00% | -6.86M |
—
|
—
|
0
|
Jan 23
| |||
Form 4
| +56.45% | 1.26M |
$27.80 | $34,999,449.40 | 3.49M |
Aug 11
| |||
Form 4
| +56.45% | 1.26M |
$27.80 | $34,999,449.40 | 3.49M |
Aug 11
| |||
Form 4
| +10.47% | 211.44K |
$181.15 | -$72,460,293.56 | 2.23M |
Mar 5
| |||
Form 4
|
—
|
0
|
$207.99 | -$80,800,259.91 | 3.42M |
Oct 30
| |||
Form 4
| +18.19% | 267.97K |
$7.86 | $2,106,212.76 | 1.74M |
Oct 3
| |||
Form 4
| +24.10% | 286.16K |
$5.60 | $1,602,512.80 | 1.47M |
Jan 6
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
BCTG Acquisition Corp. (TNGX) Snapshot price: $12.73
President
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
Pandion Therapeutics, Inc. No price found
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| -100.00% | -2.13M |
$60.00 | -$127,868,100.00 |
0
|
Apr 1
| |||
Form 4
| +113.45% | 2.13M |
$18.00 | $12,999,996.00 | 4.01M |
Jul 17 - Jul 21
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||